Role of Nitric Oxide in the Pathogenesis of Diabetic Nephropathy in Streptozotocin - Induced Diabetic Rats
Authors:
- Seong Cheol LeeSLSeong Cheol Lee
- Soo Wan KimSKSoo Wan Kim
- Nam Ho KimNKNam Ho Kim
- Young Joon KangYKYoung Joon Kang
Open Access
- 30 January 1999
- journal article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 14 (1) , 32-41
Abstract
Several reports suggest that enhanced generation or actions of nitric oxide (NO) have been implicated in the pathogenesis of glomerular hyperfiltration and hyperperfusion that occurs in early diabetes. However, the precise role of altered NO generation in the pathogenesis of diabetic nephropathy is unclear. The present study was aimed at investigating the role of nitric oxide in the pathogenesis of glomerular hyperfiltration and hyperperfusion in streptozotocin-induced diabetic rats. To evaluate the role of NO in diabetic hyperfiltration, we measured plasma and urine concentrations of NO2-/NO3-, stable metabolic products of NO and protein expressions of three isoforms of nitric oxide synthase (NOS) in streptozotocin-induced diabetic rats. We also investigated renal hemodynamic changes, such as glomerular filtration rate (GFR) and renal plasma flow (RPF), in responses to acute and chronic administration of NO synthesis inhibitor, nitro-L-arginine methyl ester (L-NAME), in diabetic and control rats. Diabetic rats exhibited significantly elevated plasma and urinary NO2-/NO3- levels at 28 days after streptozotocin injection, and total excretion of NO2-/NO3- was approximately five-fold higher in diabetic rats than controls. Insulin and L-NAME treatment prevented the increases in plasma and urinary NO2-/NO3- concentrations in diabetic rats, respectively. The three isoforms of NOS (bNOS, iNOS, and ecNOS) were all increased in the renal cortex, whereas they remained unaltered in the renal medulla at day 28. GFR and RPF were significantly elevated in diabetic rats, and acute and chronic inhibition of NO synthesis by L-NAME attenuated the renal hemodynamic changes (increases in GFR and RPF) in diabetic rats, respectively. NO synthesis was increased due to enhanced NOS expression in diabetic rats, and chronic NO blockade attenuated renal hyperfiltration and hyperperfusion in diabetic rats. In addition, diabetic rats exhibited enhanced renal hemodynamic responses to acute NO inhibition and excreted increased urinary NO2-/NO3-. These results suggest that excessive NO production may contribute to renal hyperfiltration and hyperperfusion in early diabetes.Keywords
This publication has 62 references indexed in Scilit:
- Role of macula densa NOS in tubuloglomerular feedbackCurrent Opinion in Nephrology and Hypertension, 1998
- Influence of Dietary Sodium Intake on Renal Medullary Nitric Oxide SynthaseHypertension, 1996
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJACC, 1996
- Role of Nitric Oxide in Modulating the Vasoconstrictor Actions of Angiotensin II in Preglomerular and Postglomerular Vessels in DogsHypertension, 1995
- Glomerular actions of nitric oxideKidney International, 1995
- Antagonist for Atrial Natriuretic Peptide Receptors Ameliorates Glomerular Hyperfiltration in Diabetic RatsBiochemical and Biophysical Research Communications, 1993
- Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitusKidney International, 1992
- Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor.Hypertension, 1991
- Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration.Journal of Clinical Investigation, 1987
- Predicting Diabetic Nephropathy in Insulin-Dependent PatientsNew England Journal of Medicine, 1984